Grant Pickering
Founder bei VAXCYTE, INC.
Vermögen: 53 Mio $ am 31.03.2024
Aktive Positionen von Grant Pickering
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VAXCYTE, INC. | Director/Board Member | 27.05.2013 | - |
| Chief Executive Officer | 27.05.2013 | - | |
| Founder | 27.05.2013 | - | |
| President | 27.05.2013 | 01.01.2021 | |
| ATHIRA PHARMA, INC. | Director/Board Member | 27.01.2022 | - |
| Independent Dir/Board Member | 27.01.2022 | - |
Karriereverlauf von Grant Pickering
Ehemalige bekannte Positionen von Grant Pickering
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MYMETICS CORPORATION | Director/Board Member | 22.03.2012 | 19.11.2012 |
| Chief Executive Officer | 22.03.2012 | 19.11.2012 | |
| President | 22.03.2012 | 19.11.2012 | |
| DENDREON CORPORATION | Chief Operating Officer | - | 18.11.2005 |
Juvaris BioTherapeutics, Inc.
 Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Director/Board Member | 14.03.2008 | - |
| Chief Executive Officer | 14.03.2008 | - | |
| President | 14.03.2008 | - |
Ausbildung von Grant Pickering
| The Pennsylvania State University | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 7 |
| Schweiz | 2 |
Operativ
| Director/Board Member | 4 |
| Chief Executive Officer | 3 |
| President | 3 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| MYMETICS CORPORATION | Health Technology |
| ATHIRA PHARMA, INC. | Health Technology |
| VAXCYTE, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Juvaris BioTherapeutics, Inc.
Juvaris BioTherapeutics, Inc. BiotechnologyHealth Technology Juvaris BioTherapeutics, Inc. develops novel, adjuvanted vaccines and immunotherapeutics to treat infectious disease and cancer. The company was founded by Martin D. Cleary, Jeff Fairman and Steven W. Dow in February 2003 and is headquartered in Burlingame, CA. | Health Technology |
- Börse
- Insiders
- Grant Pickering
- Erfahrung
